Pharmaceutical Technology on MSN
JPM26: GSK banks on recent AI deals to offset patent expiries
GSK noted recent deals as source of fresh revenues amid patent expiries and an AI-driven boost to drug discovery.
Noetik, an AI-native biotech company developing self-supervised machine learning and high-throughput spatial data to develop ...
GlaxoSmithKline has made a hire signaling its commitment to digital health. Karenann Terrell, former Chief Information Officer at Walmart, will start at GSK in the newly created role of Chief Digital ...
GlaxoSmithKline ( ($GB:GSK) ) has provided an update. GSK plc has disclosed that David Redfern, President of Corporate Development, and Victoria ...
Pharmaceutical Technology on MSN
GSK to file for approval of twice-yearly hep B drug on positive Phase III data
GSK will be filing for approval of bepirovirsen in hepatitis B to global regulatory authorities based on the Phase III data.
is using emerging radio frequency identification (RFID) technology as part of a pilot program to crack down on drug counterfeiting and to protect consumers. GSK said Wednesday that bottles of its HIV ...
Settlement reached over mRNA-based COVID vaccines CureVac and GSK get $740 million upfront, and royalties BioNTech's deal to buy CureVac on track GSK's own lawsuits against Pfizer, BioNTech unaffected ...
SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today a collaboration and license agreement between its subsidiary, Icagen, and GlaxoSmithKline (GSK) to ...
GSK plc GSK announced positive results from two phase III studies, B-Well 1 and B-Well 2, which evaluated its investigational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results